HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
2007

Valproic Acid Increases CAR Expression in Cancer Cells

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Segura-Pacheco Blanca, Avalos Berenice, Rangel Edgar, Velazquez Dora, Cabrera Gustavo

Primary Institution: National Cancer Institute

Hypothesis

Can valproic acid enhance the expression of the coxsackie adenovirus receptor (CAR) in cancer cells to improve gene therapy outcomes?

Conclusion

Valproic acid effectively upregulates CAR expression in various cancer cell lines and tumor samples, suggesting its potential use in enhancing adenoviral gene therapy.

Supporting Evidence

  • Valproic acid treatment led to increased CAR mRNA levels in HeLa and MCF-7 cancer cell lines.
  • CAR upregulation was also observed in tumor samples from cervical cancer patients treated with valproic acid.
  • The study suggests that valproic acid can enhance adenoviral gene delivery to cancer cells.

Takeaway

Valproic acid, a medicine used for epilepsy, can help cancer cells take in more gene therapy by making a special receptor more active.

Methodology

The study involved treating cancer cell lines and tumor samples with valproic acid and measuring CAR mRNA levels using semi-quantitative PCR.

Potential Biases

Potential bias due to the small number of clinical samples and lack of control groups in the clinical study.

Limitations

The study had a small sample size and further research is needed to establish optimal dosing and timing for valproic acid treatment.

Participant Demographics

Patients diagnosed with cervical cancer, treated with valproic acid.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-0556-5-10

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication